Transferrin receptor is necessary for development of erythrocytes and the nervous system

Abstract

Plasma iron circulates bound to transferrin (Trf), which solubilizes the ferric ion and attenuates its reactivity. Diferric Trf interacts with cell-surface Trf receptor (Trfr) to undergo receptor-mediated endocytosis into specialized endosomes. Endosomal acidification leads to iron release, and iron is transported out of the endosome through the activity of divalent metal transporter 1 (DMT1, formerly Nramp2), a transmembrane iron transporter that functions only at low pH (ref. 1). Trf and Trfr then return to the cell surface for reuse, completing a highly efficient cycle. Although the Trf cycle is assumed to be the general mechanism for cellular iron uptake, this has not been validated experimentally. Mice with hypotransferrinaemia (hpx) have little or no plasma Trf (Refs 2,3). They have severe anaemia, indicating that the Trf cycle is essential for iron uptake by erythroid cells3. Other hpx tissues, however, are generally normal, and there is a paradoxical increase in intestinal iron absorption and iron storage3,4. To test the hypothesis that the Trf cycle has unique importance for erythropoiesis, we disrupted the Trfr gene in mice. This results in elimination of the Trf cycle, but leaves other Trf functions intact. Mice lacking Trfr have a more severe phenotype than hpx mice, affecting both erythropoiesis and neurologic development. Furthermore, haploinsufficiency for Trfr results in impaired erythroid development and abnormal iron homeostasis.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Figure 1: Analysis of Trfr–/– embryos.
Figure 2: Defective erythropoiesis in embryos and yolk sacs lacking Trfr.
Figure 3: Trfr–/– embryos have kinked neural tubes.
Figure 4: Increased apoptotic cell death in neural tubes of Trfr–/– embryos.

References

  1. 1

    Fleming, M.D. et al. Nramp2 is mutated in the anemic Belgrade (b) rat: evidence of a role for Nramp2 in endosomal iron transport. Proc. Natl Acad. Sci. USA 95, 1148–1153 ( 1998).

  2. 2

    Huggenvik, J.I. et al. A splicing defect in the mouse transferrin gene leads to congenital atransferrinemia. Blood 74, 482– 486 (1989).

  3. 3

    Bernstein, S.E. Hereditary hypotransferrinemia with hemosiderosis, a murine disorder resembling human atransferrinemia. J. Lab. Clin. Med. 110, 690–705 (1987).

  4. 4

    Craven, C.M. et al. Tissue distribution and clearance kinetics of non-transferrin-bound iron in the hypotransferrinemic mouse: a rodent model for hemochromatosis. Proc. Natl Acad. Sci. USA 84, 3457– 3461 (1987).

  5. 5

    Dickinson, T.K. & Connor, J.R. Histological analysis of selected brain regions of hypotransferrinemic mice. Brain Res. 635, 169–178 (1994).

  6. 6

    Inman, R.S. & Wessling-Resnick, M. Characterization of transferrin-independent iron transport in K562 cells. Unique properties provide evidence for multiple pathways of iron uptake. J. Biol. Chem. 268, 8521–8528 (1993).

  7. 7

    Sturrock, A., Alexander, J., Lamb, J., Craven, C.M. & Kaplan, J. Characterization of a transferrin-independent uptake system for iron in HeLa cells. J. Biol. Chem. 265, 3139–3145 (1990).

  8. 8

    Gelvan, D., Fibach, E., Meyron-Holtz, E.G. & Konijn, A.M. Ferritin uptake by human erythroid precursors is a regulated iron uptake pathway. Blood 88, 3200–3207 (1996).

  9. 9

    Andrews, N.C. & Bridges, K.R. in Hematology of Infancy and Childhood (eds Nathan, D.G. & Orkin, S.H.) 423–461 (W.B. Saunders, Philadelphia, 1997).

  10. 10

    Anderson, G.J., Powell, L.W. & Halliday, J.W. Transferrin receptor distribution and regulation in the rat small intestine. Effect of iron stores and erythropoiesis. Gastroenterology 98, 576–585 (1990).

  11. 11

    Fleming, M.D. et al. Microcytic anaemia mice have a mutation in Nramp2, a candidate iron transporter gene. Nature Genet. 16 , 383–386 (1997).

  12. 12

    Parkkila, S. et al. Association of the transferrin receptor in human placenta with HFE, the protein defective in hereditary hemochromatosis. Proc. Natl Acad. Sci. USA 94, 13198– 13202 (1997).

  13. 13

    Feder, J.N. et al. The hemochromatosis gene product complexes with the transferrin receptor and lowers its affinity for ligand binding. Proc. Natl Acad. Sci. USA 95, 1472–1477 (1998).

  14. 14

    Lebron, J.A. et al. Crystal structure of the hemochromatosis protein HFE and characterization of its interaction with transferrin receptor. Cell 93, 111–123 (1998).

  15. 15

    Zhou, X.Y. et al. HFE gene knockout produces mouse model of hereditary hemochromatosis. Proc. Natl Acad. Sci. USA 95, 2492– 2497 (1998).

  16. 16

    Nehls, M. et al. Two genetically separable steps in the differentiation of thymic epithelium. Science 272, 886– 889 (1996).

  17. 17

    Laird, P.W. et al. Simplified mammalian DNA isolation procedure. Nucleic Acids Res. 19, 4293 ( 1991).

  18. 18

    Fujiwara, Y., Browne, C.P., Cuniff, K., Goff, S.C. & Orkin, S.H. Arrested development of embryonic red cell precursors in mouse embryos lacking transcription factor GATA-1. Proc. Natl Acad. Sci. USA 93, 12355–12358 (1996).

  19. 19

    Wang, L.C. et al. Yolk sac angiogenic defect and intra-embryonic apoptosis in mice lacking the Ets-related factor TEL. EMBO J. 16 , 4374–4383 (1997).

  20. 20

    Joiner, C.H. et al. Increased cation permeability in mutant mouse red blood cells with defective membrane skeletons. Blood 86, 4307–4314 (1995).

  21. 21

    Torrance, J.D. & Bothwell, T.H. in Methods in Hematolory: Iron (ed. Cook, J.D.) 104–109 (Churchill Livingstone Press, New York, 1980).

Download references

Acknowledgements

We thank A. Sharpe for providing ES cells; R. Mortenson for providing the targeting vector and advice on its use; M. Kim for technical assistance in sequencing phage clones; C. Browne for tissue culture advice; K. Cuniff for help with karyotyping; M. McDevitt for advice on embryo dissections; C. Brugnara for assistance with haematological measurements; Brigham and Women's Hospital Pathology and Hematology labs for sample analysis; S. Orkin for sharing equipment; and M. Fleming, V. Blank, V. Sellers and other members of the Andrews laboratory for reviewing the manuscript and discussing these results. N.C.A. is an investigator of the Howard Hughes Medical Institute. This work was partially supported by National Institutes Health grants HL51057 to N.C.A. and HL03503 to J.E.L.

Author information

Correspondence to Nancy Andrews.

Rights and permissions

Reprints and Permissions

About this article

Further reading